You are here

Article info

Article menu
Download PDFPDF
Letter
Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis

Authors

  1. Correspondence to Dr K Raza, MRC Centre for Immune Regulation, School of Immunity and Infection, The University of Birmingham, Birmingham B15 2TT, UK; k.raza{at}bham.ac.uk
View Full Text

Citation

Raza K, Mathsson L, Buckley CD, et al
Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis
Annals of the Rheumatic Diseases 2010;69:627-628.

Publication history

  • Accepted September 17, 2009
  • First published October 20, 2009.
Online issue publication 
October 31, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions